Thyrocare Technologies
Healthcare · NSE
↓ 107.0% vs fair value
52W Low
₹220
+71.8% from low
52W High
₹537
-29.7% from high
Valuation Gauge
Current Price
₹377
Fair Value
₹182
Fair Value Analysis
₹182
Based on free cash flow projections and balance sheet strength analysis and earnings growth potential for Healthcare sector companies | Sector-expensive: P/E at 79th percentile vs sector peers. | ROCE improving (latest 33.2%) — capital allocation becoming more efficient.
Cash Flow Analysis
40% weight
Balance Sheet Value
20% weight
Growth Valuation
40% weight
Price vs Market
Shareholding Pattern
Stock Health Score
Financially Strong
Profitability
ROE of 25.5% is above the Healthcare sector benchmark of 15% — strong returns
Debt & Leverage
D/E ratio of 0.0x is well within the Healthcare sector norm of 0.8x — strong balance sheet
Valuation vs Peers
P/E of 57.3x trades at a 64% discount to Healthcare sector median (160x) — attractively valued
Cash Flow
FCF margin of 21.3% — exceptional cash generation (₹146 Cr)
Earnings Growth
5yr EPS CAGR of -19.6% — earnings are declining (sector avg growth: 18.7%)
Dividend
Dividend yield of 2.6% provides strong shareholder returns (benchmark: 1.5%)
Sentiment Trend
Historical Returns
Key Financials
EPS (TTM)
₹6.4
P/E Ratio
57.3x
P/B Ratio
10.5x
ROE
25.5%
ROCE
26%
Debt / Equity
0.05x
Beta
0.28
Div Yield
2.5%
FCF (Cr)
₹146 Cr
Revenue (Cr)
₹687 Cr
EPS Growth 5Y
-19.6%
Mkt Cap (Cr)
₹5,825 Cr
52W High
₹536.7
52W Low
₹219.6
Book Value/Share
₹34.7
Financial History
Annual P&L data not available yet.
Peer Comparison
Healthcare| Stock | Price | Fair Value | MoS% | P/E | ROE | Signal |
|---|---|---|---|---|---|---|
Alpa Laboratories Limited | ₹62.1 | ₹198.5 | +68.7% | 9.4 | 13.4% | FAIRLY_VALUED |
Aster DM Healthcare | ₹670 | ₹1,585.8 | +57.8% | 103.2 | 7.9% | UNDERVALUED |
Unichem Laboratories Limited | ₹300 | ₹592.5 | +49.4% | 7.1 | 12.1% | FAIRLY_VALUED |
Dishman Carbogen Amcis Limited | ₹147.6 | ₹281.2 | +47.5% | 19.5 | 1.9% | FAIRLY_VALUED |
Vimta Labs Limited | ₹414.8 | ₹722.6 | +42.6% | 24.6 | 16.6% | UNDERVALUED |
Morepen Laboratories Limited | ₹38.4 | ₹52.8 | +27.2% | 21 | 10.8% | FAIRLY_VALUED |
Indraprastha Medical Corporation Limited | ₹410 | ₹462.6 | +11.4% | 20 | 20.6% | FAIRLY_VALUED |
Kronox Lab Sciences Limited | ₹133 | ₹130.7 | -1.8% | 16.9 | 24.8% | FAIRLY_VALUED |
Institutional Activity
Bulk deals, block deals, short selling & delivery volume — NSE data
Insider Trading
Company Documents
Annual reports, concall transcripts & regulatory filings
Share this Stock
Download card · Share on WhatsApp
Share on WhatsApp, Twitter, or any group — each share brings new users to Veritas Quant
What is Dalal Street saying?
r/IndiaInvestments · r/Dalal_Street_Investments · r/IndianStockMarket
No Reddit mentions found yet for THYROCARE.
StockTwits
What traders are saying right now
No StockTwits activity found for THYROCARE.
Telegram Channels
ET Markets · CNBC TV18 · Moneycontrol · Zee Business · NDTV Profit
No Telegram mentions found yet for THYROCARE.
No company news found yet.
Search Interest
Google Trends · India · Last 90 days
Trend data not yet available — check back soon.